ReviewAging and disease2025
Aβ Deposition in Extracellular Space Disrupts Glial-Neuron Communication and Triggers Alzheimer's Disease.
Review in Aging and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Brain Extracellular Space: From an Overlooked Dimension to Catalyst of a Novel Neuroscience Paradigm.Cyborg and bionic systems (Washington, D.C.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disruptions in glial-neuron communication are linked to brain diseases; however, the exact mechanisms are not yet fully understood. This review highlights the critical role of glia-neuron interactions in sustaining normal brain functions. Under physiological conditions, astrocytes, microglia and oligodendrocytes, collaboratively regulate the homeostasis of brain structures and functions through diverse communication mechanisms. Conversely, under pathological conditions, disorders in glial-neuron communication can precipitate in neurodegenerative diseases, such as Alzheimer's Disease (AD). In AD, astrocytes use APOE to increase amyloid-beta (Aβ) deposition in the brain extracellular space (ECS) and neuron death, while microglia overactivation causes Tau overexpression and oligodendrocyte demyelination, leading to communication issues. Toxic proteins, Aβ and Tau, block brain ECS and hinder the drainage of interstitial fluid (ISF) cause the vicious cycle. The obstruction of ISF drainage certainly impedes neurotransmitter transmission, nutrient delivery, and waste removal, ultimately leading to neuronal death and cognitive decline in AD, which is also a direct factor contributing to the failure of drug delivery. Age-associated formaldehyde (FA) may act as a detrimental factor that exacerbates Aβ aggregation and promotes tau hyperphosphorylation, further aggravating ECS and ISF dysfunction. Interestingly, the interrupting the pathological cycle of FA-promoted Aβ aggregation and Aβ-induced FA generation by phototherapy and nanomedicine has been found to restore the ECS architecture and ISF drainage, which effectively improves AD symptoms. Hence, the re-establishing ECS structure and communication between neurons and glial cells may offer a promising therapeutic strategy for treating AD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.